Results 231 to 240 of about 85,257 (242)

An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas

Annals of Oncology, 2013
Robert Benjamin, Andrew Evens, M Von Mehren   +2 more
exaly  

The role of bevacizumab on tumour angiogenesis and in the management of gynaecological cancers: A review

Biomedicine and Pharmacotherapy, 2018
Dinesh Kumar Chellappan, Gaurav Gupta, Jestin Chellian   +2 more
exaly  

Bevacizumab

Reactions Weekly, 2022
openaire   +1 more source

Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study

Annals of Oncology, 2018
Silvia Hofer, Sabine Rohrmann, Nicolaus Andratschke   +2 more
exaly  

Pharmacokinetics of bevacizumab after topical and intravitreal administration in human eyes

Graefe's Archive for Clinical and Experimental Ophthalmology, 2013
Iriina Barequet, Karl Csaky, Anat Loewenstein   +2 more
exaly  

Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial

Annals of Oncology, 2015
John Bridgewater, Thomas Gruenberger, Ian Chau   +2 more
exaly  

Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial

Annals of Oncology, 2014
Christos Chouaid, M J Ahn, A Rittmeyer   +2 more
exaly  

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial

Annals of Oncology, 2018
Bhawna Sirohi, Paul Lorigan, Mark Middleton   +2 more
exaly  

FDA Drug Approval Summary: Bevacizumab (Avastin®) Plus Carboplatin and Paclitaxel as First‐Line Treatment of Advanced/Metastatic Recurrent Nonsquamous Non‐Small Cell Lung Cancer

Oncologist, 2007
Martin H Cohen, Pazdur Richard
exaly  

Phase II Trial of Neoadjuvant Bevacizumab Plus Chemotherapy and Adjuvant Bevacizumab in Patients with Resectable Nonsquamous Non–Small-Cell Lung Cancers

Journal of Thoracic Oncology, 2013
Naiyer A Rizvi, Jamie Chaft, Valerie Rusch   +2 more
exaly